• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 10, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Sea worms and jellyfish treat cancer and kill insects

Bioengineer by Bioengineer
February 14, 2019
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Scientists point out the expediency of further research of marine invertebrates to isolate the antitumor compounds from them.

Scientists of the Pacific Institute of Bioorganic Chemistry (PIBOC) of the Far Eastern Branch of the Russian Academy of Sciences (FEB RAS) and the Far Eastern Federal University (FEFU) found out marine invertebrates living in Troitsa Bay, the Sea of Japan, contain biologically active compounds with strong antitumor and antimicrobial properties, and also capable of killing insects. An article on that was published in the Russian Journal of Marine Biology.

Scientists have studied 9 species of marine invertebrates — sea anemones, marine worms, nemerteans, and jellyfish — and discover they are carriers of biologically active compounds with immunostimulating properties, which have a potential to prevent a metastasis proliferation of malignant tumors.

“Marine invertebrates are a promising source of biologically active compounds that can be applied to design medical drugs of a new generation. The therapeutic effects of such compounds are of a broad range. They can be antioxidants, possess cardioprotective, analgesic, antimicrobial, antitumor, and many other properties. ” — Says Elena Leychenko, Associate Professor of the Department of Bioorganic Chemistry and Biotechnology of the School of Natural Sciences (SNS), FEFU.

Scientists consider the segmented worms Eulalia viridis and the so-called marine ‘peanut worms’ (sipunculids) Phascolostoma agassizii are of the highest pharmacological potential among all invertebrates referred to in the article. Extracts obtained from these organisms were non-toxic to mouse erythrocytes and splenocytes, showing a significant antibacterial and anti-tumor effect.

It’s noteworthy that the majority of extracts retrieved from all nine experimental samples of invertebrates were harmless to mammalian cells and at the same time toxic to insects and crustaceans. It means that the isolated compounds are suitable not only for the development of the new drugs but also for the manufacturing of effective insecticides –chemicals for combating harmful insects. In particular, the extract of the ringed worms Lepidonotuss quamatus was toxic to the larvae.

Scientists point out the expediency of further research of marine invertebrates to isolate the antitumor compounds from them.

Earlier, scientists of PIBOC within the framework of the joint PIBOC (FEB-RAS) — FEFU program “Fundamental and Applied Chemistry, Specialization – Medical Chemistry” conducted a study of actinium Heteractis magnifica. These seabed dwellers turned out to be helpful to fight Alzheimer’s disease. Anemones of this kind contain peptides with neuroprotective activity. They slow down the inflammatory process and the accompanying destruction of cell neurons causing Alzheimer’s disease for the treatment of which currently there is no medicine.

###

Media Contact
Alexander Zverev
[email protected]
http://dx.doi.org/10.1134/S106307401806007X

Tags: BiochemistryBiodiversityBiologyBiotechnologycancerMarine/Freshwater BiologyMicrobiologyMolecular Biology
Share12Tweet8Share2ShareShareShare2

Related Posts

Bioengineered Lymph Nodes Provide New Insights into Human Immunity

September 10, 2025

Comprehensive Study Assesses Cancer Diagnosis Pathway for Patients Presenting Non-Specific Symptoms

September 10, 2025

Mapping Cancer Care Reach in Germany’s Centers

September 10, 2025

Unraveling AML Origins and Relapse via Systems Biology

September 10, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    57 shares
    Share 23 Tweet 14
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Beneath the Surface: Emerging Consensus Illuminates Cemental Tears

Journal of Psychiatry and Neuroscience Joins Canadian Science Publishing Portfolio

Bioengineered Lymph Nodes Provide New Insights into Human Immunity

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.